ANIX Anixa Biosciences Inc
Company Analysis
Latest News
Anixa Biosciences Upgraded to Strong Buy Following Narrower Quarterly Loss
Zacks Research upgraded Anixa Biosciences from a hold to a strong-buy recommendation. The upgrade follows the clinical-stage immuno-oncology company...
🟢 Anixa Biosciences is trading 5.3% up today despite no clear catalyst
Anixa Biosciences is trading 5.3% up at $3.71 despite a lack of fresh company-specific news, regulatory updates, or analyst calls hitting the wires. • The...
🟢 Anixa Biosciences is trading 6.1% up today amid a broader biotech rally and oncology pipeline optimism
Anixa Biosciences is trading 6.1% up at $3.67 today, driven by a broader biotech sector rally and positive sentiment surrounding its oncology pipeline. • The...
🟢 Anixa Biosciences is trading 5.9% up today with no clear company-specific catalyst
Anixa Biosciences is trading at $3.60 (+5.88%) in pre-market following a modest late-week rebound despite a lack of fresh company-specific news. • The upward...
🟢 Anixa Biosciences is trading 6.5% up today as it rebounds from recent biotech sector volatility
Anixa Biosciences is trading at $3.62 (6.5% up) in after-hours, rebounding from recent biotech-sector weakness and volatility earlier this week. • The move...
🔴 Anixa Biosciences is trading 7.6% down today amid broader biotech sector weakness
Anixa Biosciences is trading at $3.14 (7.6% down) in after-hours, reversing its 5.1% regular-session rebound as the broader biotech sector remains under...
🟢 Anixa Biosciences is trading 5.1% up today, rebounding despite a broader biotech sector sell-off
Anixa Biosciences is trading 5.1% up today at $3.49, rebounding from a previous session drop despite a broader market downturn. • The stock is significantly...
🟢 Anixa Biosciences is trading 10.2% up
Anixa Biosciences is trading at $3.66, up 10.2% from a comparison close of $3.32 during pre-market. This is a price-action follow-up, so a separate catalyst...
Anixa's Australian Patent Win Fuels a 19% Weekly Rally — But Can IP Filings Alone Justify the Bet on a Pre-Revenue Cancer Biotech?
Shares of Anixa Biosciences surged 9.6% to $3.64 in pre-market trading, extending a week-long rally of roughly 19% from $3.06 on July 10. The catalyst: IP...
🟢 Anixa Biosciences is trading 9.6% up today after Australian patent acceptance for breast cancer vaccine technology
Anixa Biosciences is trading at $3.64 (+9.64%) after the company announced that IP Australia issued a Notice of Acceptance for a new patent protecting its...
🟢 Anixa Biosciences is trading 5.4% up today after Australian patent acceptance
Anixa Biosciences is trading at $3.50 (+5.42%) following sustained momentum from its Australian patent acceptance for breast cancer vaccine technology. • The...
🟢 Anixa Biosciences is trading 5.7% up today after Australian patent acceptance for breast cancer vaccine
Anixa Biosciences is trading at $3.70 (+5.71%) in pre-market following news of a patent acceptance in Australia for its breast cancer vaccine technology. •...
🟢 Anixa Biosciences is trading 10.7% up
Anixa Biosciences is trading at $3.53, up 10.7% from a comparison close of $3.19 during regular trading. This is a price-action follow-up, so a separate...
🟢 Anixa Biosciences is trading 6% up today after Australian patent acceptance for breast cancer vaccine
Anixa Biosciences is trading 5.6% up now at $3.37 after announcing Australian patent acceptance for its novel breast cancer vaccine platform. • The new patent...
Anixa Biosciences Secures Australian Patent for Aggressive Breast Cancer Vaccine
Anixa Biosciences received a notice of allowance from the Australian Patent Office for its novel breast cancer vaccine technology. The company is developing...
🟢 Anixa Biosciences is trading 5.6% up today on continued momentum from cancer therapy trials and a recent patent allowance
Anixa Biosciences is trading 5.6% up at $3.23 as investors focus on the company's ovarian cancer CAR-T/CER-T program and breast cancer vaccine developments. •...
🟢 Anixa Biosciences is trading 6.6% up today as it rebounds from a recent pullback amid trial momentum
Anixa Biosciences is trading at $3.26 (up 6.6%) in pre-market, rebounding from a 4.97% pullback to $3.06 on July 10. • The upward move follows continued...
🔴 Anixa Biosciences is trading 6.8% down today in a likely pullback after recent gains
Anixa Biosciences is trading 6.8% down at $3.00 in a likely pullback following several strong sessions earlier this week. • No new company-specific news or...
🟢 Anixa Biosciences is trading 5.47% up today as momentum continues
Anixa Biosciences is trading at $3.28 (+5.47%) in pre-market as it extends recent momentum following a strong session on July 8. • The move appears to be a...
🟢 ANIX extends move to 5.9% up
ANIX is trading at $3.13, up 5.9% versus the comparison close of $2.96 during regular trading. This is a price-movement alert; no separate company-specific...